Long noncoding RNA linc00467 plays an oncogenic role in hepatocellular carcinoma by regulating the miR-18a-5p/NEDD9 axis
- PMID: 31916278
- DOI: 10.1002/jcb.29581
Long noncoding RNA linc00467 plays an oncogenic role in hepatocellular carcinoma by regulating the miR-18a-5p/NEDD9 axis
Abstract
Increasing evidence has shown that numerous long noncoding RNAs (lncRNAs) play critical roles in tumorigenesis. Herein, we investigated the biological role of lncRNA linc00467 in the cancer biology of hepatocellular carcinoma (HCC). We observed that linc00467 was upregulated in HCC tissues and cells. Silencing of linc00467 using small interfering RNA interference significantly inhibited the growth and motility of HCC cells, and increased cell apoptosis through regulating the Bcl-2/Bax axis and the caspase cascade, suggesting that linc00467 exerted oncogenic functions in the progression of HCC. Moreover, we found that linc00467 could target miR-18a-5p, and NEDD9 was a target for miR-18a-5p in HCC cells. Furthermore, either the miR-18a-5p inhibitor or upregulation of NEDD9 could recover the inhibitory effects caused by silencing of linc00467. In conclusion, our data highlighted the oncogenic role of linc00467 in HCC progression by regulating the miR-18a-5p/NEDD9 axis.
Keywords: NEDD9; hepatocellular carcinoma; linc00467; miR-18a-5p.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
A review on the role of LINC00467 in the carcinogenesis.Cancer Cell Int. 2022 Oct 13;22(1):319. doi: 10.1186/s12935-022-02724-6. Cancer Cell Int. 2022. PMID: 36229833 Free PMC article. Review.
-
Long non-coding RNA LINC00467 drives hepatocellular carcinoma progression via inhibiting NR4A3.J Cell Mol Med. 2020 Apr;24(7):3822-3836. doi: 10.1111/jcmm.14942. Epub 2020 Mar 3. J Cell Mol Med. 2020. PMID: 32125766 Free PMC article.
-
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.Mol Cancer. 2019 Feb 19;18(1):28. doi: 10.1186/s12943-019-0957-7. Mol Cancer. 2019. PMID: 30782188 Free PMC article.
-
Long non-coding RNA LINC00467 regulates hepatocellular carcinoma progression by modulating miR-9-5p/PPARA expression.Open Biol. 2019 Sep 27;9(9):190074. doi: 10.1098/rsob.190074. Epub 2019 Sep 4. Open Biol. 2019. PMID: 31480990 Free PMC article. Retracted.
-
LINC00467: A key oncogenic long non-coding RNA.Clin Chim Acta. 2022 Nov 1;536:112-125. doi: 10.1016/j.cca.2022.09.013. Epub 2022 Sep 16. Clin Chim Acta. 2022. PMID: 36122666 Review.
Cited by
-
LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.Am J Cancer Res. 2023 Nov 15;13(11):5590-5609. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058825 Free PMC article.
-
Protective effect of miR-18a in resected liver metastases of colorectal cancer and FOLFOX treatment.Cancer Rep (Hoboken). 2023 Dec;6(12):e1899. doi: 10.1002/cnr2.1899. Epub 2023 Sep 12. Cancer Rep (Hoboken). 2023. PMID: 37698257 Free PMC article.
-
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.Pharmaceutics. 2023 Apr 15;15(4):1249. doi: 10.3390/pharmaceutics15041249. Pharmaceutics. 2023. PMID: 37111734 Free PMC article. Review.
-
A review on the role of LINC00467 in the carcinogenesis.Cancer Cell Int. 2022 Oct 13;22(1):319. doi: 10.1186/s12935-022-02724-6. Cancer Cell Int. 2022. PMID: 36229833 Free PMC article. Review.
-
LINC00467: an oncogenic long noncoding RNA.Cancer Cell Int. 2022 Oct 7;22(1):303. doi: 10.1186/s12935-022-02733-5. Cancer Cell Int. 2022. PMID: 36203193 Free PMC article. Review.
References
REFERENCES
-
- Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 2012;4:19-37. https://doi.org/10.2147/HMER.S16316
-
- Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):835-853. https://doi.org/10.1053/j.gastro.2015.12.041
-
- Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1. https://doi.org/10.4103/jcar.JCar_9_16
-
- Yang PC, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma. World J Hepatol. 2016;8(31):1309-1317. https://doi.org/10.4254/wjh.v8.i31.1309
-
- Wong CM, Ng IO. Molecular pathogenesis of hepatocellular carcinoma. Liver Int. 2008;28(2):160-174. https://doi.org/10.1111/j.1478-3231.2007.01637.x
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
